Role of Serum Albumin as a Prognostic marker of mortality and duration of hospital stay among Diabetic Ketoacidosis Patients.
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 2, Pages 2580-2584
AbstractAbstract: Background: Diabetic Ketoacidosis (DKA) is an critical and menacing problem
of Type 1 as well as type 2 diabetes mellitus (T2DM). DKA is associated with high amount
of risk of mortality and morbidity (hospital stay). The prognostic factors of DKA are
important factors affecting the outcome of the patients (as treated or death). S. Albumin is
one of the prognostic factor less studied up till now.
Objectives: To determine Clinical profile of DKA patients: aetiologies, precipitating
factors, biochemical parameters and other complications of T2DM patients and to corelate
serum albumin level with mortality, duration of stay among DKA patients.
Methodology: This cross sectional study will be conducted among 100 diabetic patients
with and without ketoacidosis from May 2019 to May 2021. Biochemical parameters:
glycated Haemoglobin, urine ketones and serum albumin will be gathered to determine the
prognosis. Controls will be adult diabetic patients without ketoacidosis. Data from Cases
and controls will be statistically analysed and then compared accordingly.
Expected Results: It is expected that decreased Sr. albumin will be associated with poor
prognosis in DKA patients. Sr. Albumin might be an indirect prognostic marker of diabetes
control due anabolic effect of Insulin, which affects both ketosis possibility and glucose
- Article View: 166
- PDF Download: 486